Altimmune to Provide Corporate Update at the Rodman & Renshaw Global Investment Conference
Sep 06, 2017 12:02 pm UTC| Business
GAITHERSBURG, Md., Sept. 06, 2017 -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that Bill Enright, President and Chief Executive Officer of Altimmune, will present a...
Offer to Purchase Select Sands’ Ownership Position in Comstock Metals Extended to September 8, 2017
Sep 06, 2017 12:02 pm UTC| Business
VANCOUVER, British Columbia, Sept. 06, 2017 -- Select Sands Corp. (“Select Sands” or the “Company”) (TSX-V:SNS) (OTC:SLSDF) today announced that the offer from SJ Strategic Investments, LLC, Gracetree Investments, LLC,...
Lifespan Hospital Company selects IDdriven Identity and Access Management SaaS Service
Sep 06, 2017 12:02 pm UTC| Business
SACRAMENTO, Calif., Sept. 06, 2017 -- IDdriven, Inc., (OTC:IDDR), an innovative provider of premises and cloud-based Identity and Access Management ("IAM") solutions is pleased to announce today that Rhode Island based...
Sep 06, 2017 12:01 pm UTC| Business
WESTPORT, Conn., Sept. 06, 2017 -- The future of HVACR will be on display in January when hundreds of new and upgraded products and technologies for the HVACR industry will be featured at the 2018 AHR Expo...
Poseida Therapeutics Presents Novel BCMA-Specific CAR-T Therapy at CAR-TCR Summit
Sep 06, 2017 12:01 pm UTC| Business
SAN DIEGO, Sept. 06, 2017 -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene editing technologies into lifesaving cell therapies, today presented preclinical data on...
Semtech Demonstrates Optical Networking IC Industry Leadership Internationally
Sep 06, 2017 12:01 pm UTC| Business
CAMARILLO, Calif., Sept. 06, 2017 -- Semtech Corporation (Nasdaq:SMTC), a leading supplier of high performance analog and mixed-signal semiconductors and advanced algorithms, is exhibiting its comprehensive platform of...
Clementia Pharmaceuticals to Participate in Upcoming Investor Conferences
Sep 06, 2017 12:01 pm UTC| Business
MONTREAL, Sept. 06, 2017 -- Clementia Pharmaceuticals Inc. (NASDAQ:CMTA), a clinical stage biopharmaceutical company, today announced that Dr. Clarissa Desjardins, CEO of Clementia Pharmaceuticals, will participate in...